ZM 447439

  ( 33 citations )    
Product Datasheet
Catalog Number:2458
Chemical Name:N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamide
Product Details
Citations (33)
Reviews
Biological Activity
Novel, selective ATP-competitive inhibitor of Aurora B kinase in vitro (IC50 values are 50, 250 and 1000 nM for Aurora B, C and A kinases respectively). Selective over a range of other kinases including cdk1 and PLK1 (IC50 > 10 μM). Inhibits cell division and displays selective toxicity towards proliferating tumor cells versus non-dividing cells.
Technical Data
  • M.Wt:
    513.59
  • Formula:
    C29H31N5O4
  • Solubility:
    Soluble to 100 mM in DMSO
  • Purity:
    >98
  • Storage:
    Store at -20°C
  • CAS No:
    331771-20-1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis. All Tocris products are intended for laboratory research use only.
Additional Information
Licensing Caveats:
Sold with the permission of AstraZeneca UK Ltd.
Product Datasheets
COA view current batch
or select another batch:
Citations:

The citations listed below are publications that use Tocris products. Selected citations for ZM 447439 include:

33 Citations: Showing 1 - 10
Filter your results:

  1. Aurora-B kinase pathway controls the lateral to end-on conversion of kinetochore-microtubule attachments in human cells.
    Authors: Shrestha
    Nat Commun  2017;8(1):150
  2. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells.
    Authors: Hindriksen Et al.
    PLoS One  2017;12:e0179514
  3. Stable kinetochore-microtubule attachment is sufficient to silence the spindle assembly checkpoint in human cells.
    Authors: Tauchman Et al.
    J Cell Sci  2015;6:10036
  4. Mio depletion links mTOR regulation to Aurora A and Plk1 activation at mitotic centrosomes.
    Authors: Platani Et al.
    J Cell Biol  2015;210:45
  5. Multiple assembly mechanisms anchor the KMN spindle checkpoint platform at human mitotic kinetochores.
    Authors: Kim and Yu
    J Cell Biol  2015;208:181
  6. Phosphorylation of myosin II-interacting guanine nucleotide exchange factor (MyoGEF) at threonine 544 by aurora B kinase promotes the binding of polo-like kinase 1 to MyoGEF.
    Authors: Wu Et al.
    J Biol Chem  2014;289:7142
  7. Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na.
    Authors: Mäki-Jouppila Et al.
    Nat Commun  2014;13:1054
  8. Selective disruption of aurora C kinase reveals distinct functions from aurora B kinase during meiosis in mouse oocytes.
    Authors: Balboula and Schindler
    PLoS Genet  2014;10:e1004194
  9. Oocytes isolated from dairy cows with reduced ovarian reserve have a high frequency of aneuploidy and alterations in the localization of progesterone receptor membrane component 1 and aurora kinase B.
    Authors: Luciano Et al.
    Biol Reprod  2013;88:58
  10. Aurora B spatially regulates EB3 phosphorylation to coordinate daughter cell adhesion with cytokinesis.
    Authors: Ferreira Et al.
    J Cell Biol  2013;201:709
  11. Spatiotemporal organization of Aurora-B by APC/CCdh1 after mitosis coordinates cell spreading through FHOD1.
    Authors: Floyd Et al.
    Cell Cycle  2013;126:2845
  12. In vivo FRET imaging revealed a regulatory role of RanGTP in kinetochore-microtubule attachments via Aurora B kinase.
    Authors: Lee Et al.
    PLoS One  2012;7:e45836
  13. Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation.
    Authors: Wang Et al.
    J Cell Biol  2012;199:251
  14. Appearance and heterochromatin localization of HP1α in early mouse embryos depends on cytoplasmic clock and H3S10 phosphorylation.
    Authors: Meglicki Et al.
    Cell Cycle  2012;11:2189
  15. The chromosomal passenger complex activates Polo kinase at centromeres.
    Authors: Carmena Et al.
    PLoS Biol  2012;10:e1001250
  16. Aurora kinase B activity is modulated by thyroid hormone during transcriptional activation of pituitary genes.
    Authors: Tardáguila Et al.
    Mol Endocrinol  2011;25:385
  17. Zwint-1 is a novel Aurora B substrate required for the assembly of a dynein-binding platform on kinetochores.
    Authors: Kasuboski Et al.
    Mol Biol Cell  2011;22:3318
  18. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.
    Authors: Yuan Et al.
    Am J Pathol  2011;179:2091
  19. Formation of stable attachments between kinetochores and microtubules depends on the B56-PP2A phosphatase.
    Authors: Foley Et al.
    Nat Cell Biol  2011;13:1265
  20. Role of a novel coiled-coil domain-containing protein CCDC69 in regulating central spindle assembly.
    Authors: Pal Et al.
    J Am Soc Nephrol  2010;9:4117
  21. VHL inactivation induces HEF1 and Aurora kinase A.
    Authors: Xu Et al.
    J Cell Biol  2010;21:2041
  22. Relocation of the chromosomal passenger complex prevents mitotic checkpoint engagement at anaphase.
    Authors: Vázquez-Novelle and Petronczki
    Curr Biol  2010;20:1402
  23. Plk1 negatively regulates Cep55 recruitment to the midbody to ensure orderly abscission.
    Authors: Bastos and Barr
    J Cell Biol  2010;191:751
  24. Release of Mps1 from kinetochores is crucial for timely anaphase onset.
    Authors: Jelluma Et al.
    Cell Cycle  2010;191:281
  25. Epigenetic centromere specification directs aurora B accumulation but is insufficient to efficiently correct mitotic errors.
    Authors: Bassett Et al.
    Mol Cancer Ther  2010;190:177
  26. Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase.
    Authors: Manchado Et al.
    Cancer Cell  2010;18:641
  27. Human condensin function is essential for centromeric chromatin assembly and proper sister kinetochore orientation.
    Authors: Samoshkin Et al.
    PLoS One  2009;4:e6831
  28. Discovery and exploitation of inhibitor-resistant aurora and polo kinase mutants for the analysis of mitotic networks.
    Authors: Scutt Et al.
    J Biol Chem  2009;284:15880
  29. The Nup107-160 nucleoporin complex promotes mitotic events via control of the localization state of the chromosome passenger complex.
    Authors: Platani Et al.
    Mol Biol Cell  2009;20:5260
  30. Cell cycle dependent degradation of MCAK: evidence against a role in anaphase chromosome movement.
    Authors: Ganguly Et al.
    Toxins (Basel)  2008;7:3187
  31. A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin.
    Authors: Slawson Et al.
    Mol Biol Cell  2008;19:4130
  32. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.
    Authors: Gascoigne and Taylor
    Cancer Cell  2008;14:111
  33. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients.
    Authors: Vischioni Et al.
    Mol Cancer Ther  2006;5:2905
Expand to show all Citations

FAQs

No product specific FAQs exist for this product, however you may

View all Small Molecule FAQs

Have you used ZM 447439?

Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.

Order Details

Contact Us to Order
reload

Feedback

Customer Information
Calculators

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

R&D Systems Guarantee